BOSTON SCIENTIFIC CORP — Director's Dealing 2019

Aug 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-08-15

Reporting Person: Butcher Arthur C (SVP&Pres, Endoscopy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-15	Common Stock	M	3874.0000	$7.1600	Acquired	19745.0000	Direct
2019-08-15	Common Stock	S	6329.0000	$41.9782	Disposed	13416.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-15	Stock Option (Right to Buy)	$7.1600	M	3874.0000	Disposed	2021-02-28	Common Stock (3874.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2558.0000	Indirect

Footnotes

F1: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at $41.9537 and $41.9937. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.